Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer.

Fang, Ze-Xuan; Li, Chun-Lan; Chen, Wen-Jia; Wu, Hua-Tao; Liu, Jing

Fang, Ze-Xuan; Li, Chun-Lan; Chen, Wen-Jia; Wu, Hua-Tao; Liu, Jing.

Afiliação

Fang ZX; Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China.
Li CL; Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China.
Chen WJ; Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China.
Wu HT; Department of General Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China.
Liu J; Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong Province, China. jliu12@stu.edu.cn.

World J Gastrointest Oncol ; 14(9): 1675-1688, 2022 Sep 15.

Article em En | MEDLINE | ID: mdl-36187390

Palavras-chave

Colorectal cancer; Immunotherapy; Six-transmembrane epithelial antigen of the prostate; Survival; Target

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: World J Gastrointest Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google